NHS could offer thousands new test that spots oesophageal cancer risk before it develops

Resumen detallado
A seven-minute "sponge on a string" test could be rolled out across the NHS to help identify patients at higher risk of oesophageal cancer.
Thousands of patients across England could be offered a new seven-minute NHS test to detect a condition that increases their risk of developing oesophageal cancer.
Two capsule sponge tests, known as Cytosponge and EndoSign, have been recommended for use on the health service under new draft guidance from the National Institute for Health and Care Excellence (Nice).
The technology is designed to identify Barrett's oesophagus, a condition in which stomach acid damages the lining of the food pipe. Abnormal changes to cells can sometimes lead to cancer.
The test involves swallowing a small capsule attached to a string. Once inside the stomach, the capsule dissolves to release a sponge, which is then pulled back up to collect cells from the lining of the oesophagus for laboratory analysis.
To see more of the stories you love from The Mirror and to find them easily in Google then make us your preferred source. Free and easy-to-do, just click on the link here to find more from The Mirror at the top of your feed.
Already trialled in pilot schemes, the tests can be carried out at GP surgeries, pharmacies and community diagnostic centres without the need for sedation.
Nice said its committee found patients prefer the sponge on a string test to endoscopy, which involves a thin tube with a camera at the end being passed through the throat.
More than 9,000 people are diagnosed with oesophageal cancer in the UK each year, with the disease often detected at a later stage when it is harder to treat.
According to Nice, Barrett’s oesophagus impacts around 1% to 2% of adults, and is common among those who have long-term acid reflux.
Inicio del artículo, extracto de Daily Mirror. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.mirror.co.uk)





